{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:32:17Z","timestamp":1768865537117,"version":"3.49.0"},"reference-count":37,"publisher":"Societatea Romana de Morfologie","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rom J Morphol Embryol"],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>Background: Breast cancer (BC) remains one of the most prevalent malignancies worldwide, and its progression can be influenced by systemic conditions such as type 2 diabetes mellitus (T2DM). Both diseases share common mechanisms of metabolic dysregulation, chronic inflammation, and vascular dysfunction that may reshape the tumor microenvironment (TME). Aim: To conduct a comparative evaluation of the vascular and immune components of the BC microenvironment in patients with and without T2DM, as well as in normal mammary tissue, with particular emphasis on cluster of differentiation (CD)34+ microvessel density (MVD), T-cell subsets (CD3+, CD4+, CD8+), and their association with hormonal receptor status and proliferative index (Ki67). Materials and Methods: Immunohistochemical analysis was performed on 58 invasive ductal carcinomas (29 T2DM-associated, 29 non-diabetic) and 10 normal breast samples. Quantification of immune and vascular markers was correlated with clinical and morphological parameters using Spearman\u2019s test and Welch statistics (p\u22640.05). Results: T2DM-associated BCs demonstrated significantly increased intratumoral MVD (p=0.03) and decreased intratumoral CD3+, CD4+, and CD8+ lymphocytes compared with non-diabetic tumors, indicating an immune-excluded phenotype. Blood glucose correlated positively with CD34+ vessel content and inversely with Ki67 expression (rs=-0.29, p=0.05). Peritumoral CD8+ cells were positively associated with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status, suggesting hormonal modulation of immune infiltration. Conclusions: T2DM promotes vascular proliferation and suppresses intratumoral immune activity in BC, creating an angiogenic yet immunosuppressed microenvironment. These findings highlight the impact of metabolic imbalance on tumor biology and underscore the need for integrating metabolic control and immunomodulatory strategies in the management of diabetic BC patients.<\/jats:p>","DOI":"10.47162\/rjme.66.3.12","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:41:45Z","timestamp":1768819305000},"page":"553-561","source":"Crossref","is-referenced-by-count":0,"title":["The influence of diabetes mellitus on blood vessels\u2019 amounts and immune status in case of breast cancer"],"prefix":"10.47162","volume":"66","author":[{"name":"Department of Histology, Cytology and Embryology, Nicolae Testemi\u0163anu State University of Medicine and Pharmacy, Chi\u015fin\u0103u, Republic of Moldova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecaterina","family":"Foca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dumitru","family":"Brinza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Public Medical Sanitary Institution Institute of Oncology, Chi\u015fin\u0103u, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecaterina","family":"Carpenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Histology, Cytology and Embryology, Nicolae Testemi\u0163anu State University of Medicine and Pharmacy, Chi\u015fin\u0103u, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriu","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Histology, Cytology and Embryology, Nicolae Testemi\u0163anu State University of Medicine and Pharmacy, Chi\u015fin\u0103u, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Saptefrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Histology, Cytology and Embryology, Nicolae Testemi\u0163anu State University of Medicine and Pharmacy, Chi\u015fin\u0103u, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veaceslav","family":"Fulga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Histology, Cytology and Embryology, Nicolae Testemi\u0163anu State University of Medicine and Pharmacy, Chi\u015fin\u0103u, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26736","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"\"[1] Jordt N, Kj\u00e6rgaard KA, Thomsen RW, Borgquist S, Cronin-Fenton D. Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Breast Cancer Res Treat, 2023, 202(1):11-12. https:\/\/doi.org\/10.1007\/s10549-023-07043-6","DOI":"10.1007\/s10549-023-07043-6"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"[2] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3):229-263. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"[3] Zhang C, Le A. Diabetes and cancer: the epidemiological and metabolic associations. Adv Exp Med Biol, 2021, 1311:217-227. https:\/\/doi.org\/10.1007\/978-3-030-65768-0_16","DOI":"10.1007\/978-3-030-65768-0_16"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"[4] Bosso M, Haddad D, Al Madhoun A, Al-Mulla F. Targeting the metabolic paradigms in cancer and diabetes. Biomedicines, 2024, 12(1):211. https:\/\/doi.org\/10.3390\/biomedicines12010211","DOI":"10.3390\/biomedicines12010211"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"[5] Martino F, Lupi M, Giraudo E, Lanzetti L. Breast cancers as ecosystems: a metabolic perspective. Cell Mol Life Sci, 2023, 80(9):244. https:\/\/doi.org\/10.1007\/s00018-023-04902-9","DOI":"10.1007\/s00018-023-04902-9"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"[6] Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell, 2023, 186(8):1708-1728. https:\/\/doi.org\/10.1016\/j.cell.2023.01.040","DOI":"10.1016\/j.cell.2023.01.040"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"[7] Sankofi BM, Valencia-Rinc\u00f3n E, Sekhri M, Ponton-Almodovar AL, Bernard JJ, Wellberg EA. The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism. Front Endocrinol (Lausanne), 2023, 14:1217875. https:\/\/doi.org\/10.3389\/fendo.2023.1217875","DOI":"10.3389\/fendo.2023.1217875"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"[8] Ahmed SBM, Radwan N, Amer S, Saheb Sharif-Askari N, Mahdami A, Samara KA, Halwani R, Jelinek HF. Assessing the link between diabetic metabolic dysregulation and breast cancer progression. Int J Mol Sci, 2023, 24(14):11816. https:\/\/doi.org\/10.3390\/ijms241411816","DOI":"10.3390\/ijms241411816"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"[9] Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, Sapino A, Sasano H, Schnitt S, Sotiriou C, van Diest P, White VA, Lokuhetty D, Cree IA; WHO Classification of Tumours Editorial Board. The 2019 World Health Organization classification of tumours of the breast. Histopathology, 2020, 77(2):181-185. https:\/\/doi.org\/10.1111\/his.14091","DOI":"10.1111\/his.14091"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"[10] Bertero L, Massa F, Metovic J, Zanetti R, Castellano I, Ricardi U, Papotti M, Cassoni P. Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria - what has changed and why? Virchows Arch, 2018, 472(4):519-531. https:\/\/doi.org\/10.1007\/s00428-017-2276-y","DOI":"10.1007\/s00428-017-2276-y"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"[11] Carpenco E, Ceau\u015fu RA, Cimpean AM, Gaje PN, \u015eaptefra\u0163i L, Fulga V, David V, Raica M. Mast cells as an indicator and prognostic marker in molecular subtypes of breast cancer. In Vivo, 2019, 33(3):743-748. https:\/\/doi.org\/10.21873\/invivo.11534","DOI":"10.21873\/invivo.11534"},{"key":"ref11","unstructured":"[12] Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 1998, 11(2):155-168."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"[13] Foca E, Brinza D, Portnoi E, Carpenco E, David V, Saptefrati L, Fulga V. The influence of diabetes mellitus on blood vessels amount in case of breast cancer. Mold J Health Sci, 2023, 10(1):3-8. https:\/\/doi.org\/10.52645\/MJHS.2023.1.01","DOI":"10.52645\/MJHS.2023.1.01"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"[14] Wang Y, Zhu N, Liu J, Chen F, Song Y, Ma Y, Yang Z, Wang D. Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. J Transl Med, 2025, 23(1):539. https:\/\/doi.org\/10.1186\/s12967-025-06508-0","DOI":"10.1186\/s12967-025-06508-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"[15] Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med, 2012, 2012:918267. https:\/\/doi.org\/10.1155\/2012\/918267","DOI":"10.1155\/2012\/918267"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"[16] Garstka MA, Kedzierski L, Maj T. Diabetes can impact cellular immunity in solid tumors. Trends Immunol, 2025, 46(4):295-309. https:\/\/doi.org\/10.1016\/j.it.2025.02.014","DOI":"10.1016\/j.it.2025.02.014"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"[17] Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011, 473(7347):298-307. https:\/\/doi.org\/10.1038\/nature10144","DOI":"10.1038\/nature10144"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"[18] van der Putten C, Remmerswaal EBM, Terpstra ML, van der Bom ND, Kers J, ten Berge IJM, Geerlings SE, van Lier RAW, Bemelman FJ, van Aalderen MC. CD8 and CD4 T cell populations in human kidneys. Cells, 2021, 10(2):288. https:\/\/doi.org\/10.3390\/cells10020288","DOI":"10.3390\/cells10020288"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"[19] Culha Y, Ozdemir C, Davarci SE, \u00dcnl\u00fc B, Olgun AKM, Demir H, Baykara M. Clinical and prognostic effects of microvascular density and FOXP3-positive T cells in breast cancer. Sci Rep, 2024, 14(1):30341. https:\/\/doi.org\/10.1038\/s41598-024-82106-2","DOI":"10.1038\/s41598-024-82106-2"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"[20] Fuller AM, Olsson LT, Midkiff BR, Kirk EL, McNaughton KK, Calhoun BC, Troester MA. Vascular density of histologically benign breast tissue from women with breast cancer: associations with tissue composition and tumor characteristics. Hum Pathol, 2019, 91:43-51. https:\/\/doi.org\/10.1016\/j.humpath.2019.06.003","DOI":"10.1016\/j.humpath.2019.06.003"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"[21] Liu T, Sun B, Zhao X, Gu Q, Dong X, Yao Z, Zhao N, Chi J, Liu N, Sun R, Ma Y. HER2\/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma. J Cell Mol Med, 2013, 17(1):116-122. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01653.x","DOI":"10.1111\/j.1582-4934.2012.01653.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"[22] Kilickap S, Kaya Y, Yucel B, Tuncer E, Babacan NA, Elagoz S. Higher Ki67 expression is associated with unfavorable prognostic factors and shorter survival in breast cancer. Asian Pac J Cancer Prev, 2014, 15(3):1381-1385. https:\/\/doi.org\/10.7314\/apjcp.2014.15.3.1381","DOI":"10.7314\/APJCP.2014.15.3.1381"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"[23] Miyan M, Schmidt-Mende J, Kiessling R, Poschke I, de Boniface J. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. J Transl Med, 2016, 14(1):227. https:\/\/doi.org\/10.1186\/s12967-016-0983-9","DOI":"10.1186\/s12967-016-0983-9"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"[24] Guo G, Wang Y, Zhou Y, Quan Q, Zhang Y, Wang H, Zhang B, Xia L. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J Immunother Cancer, 2019, 7(1):179. https:\/\/doi.org\/10.1186\/s40425-019-0656-3","DOI":"10.1186\/s40425-019-0656-3"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"[25] Berben L, Floris G, Kenis C, Dalmasso B, Smeets A, Vos H, Neven P, Antoranz Martinez A, Laenen A, Wildiers H, Hatse S. Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer. Clin Transl Immunol, 2020, 9(10):e1184. https:\/\/doi.org\/10.1002\/cti2.1184","DOI":"10.1002\/cti2.1184"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"[26] Ontiveros CO, Murray CE, Crossland G, Curiel TJ. Considerations and approaches for cancer immunotherapy in the aging host. Cancer Immunol Res, 2023, 11(11):1449-1461. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0121","DOI":"10.1158\/2326-6066.CIR-23-0121"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"[27] Imaizumi K, Suzuki T, Kojima M, Shimomura M, Sakuyama N, Tsukada Y, Sasaki T, Nishizawa Y, Taketomi A, Ito M, Nakatsura T. Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer. Cancer Sci, 2020, 111(1):23-35. https:\/\/doi.org\/10.1111\/cas.14223","DOI":"10.1111\/cas.14223"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"[28] Mitchell KG, Parra ER, Nelson DB, Zhang J, Wistuba II, Fujimoto J, Roth JA, Antonoff MB; MD Anderson Lung Cancer Immune Microenvironment Working Group. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2019, 158(3):911-919.e6. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.04.084","DOI":"10.1016\/j.jtcvs.2019.04.084"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"[29] Zhu H, Roelands J, Ahmed EI, Stouten I, Hoorntje R, van Vlierberghe RLP, Ijsselsteijn ME, Lei X, de Miranda NFCC, Tollenaar RAEM, Vahrmeijer AL, Bedognetti D, Hendrickx WRL, Kuppen PJK. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer. Front Immunol, 2024, 15:1293618. https:\/\/doi.org\/10.3389\/fimmu.2024.1293618","DOI":"10.3389\/fimmu.2024.1293618"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"[30] Fridman WH, Zitvogel L, Saut\u00e8s-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol, 2017, 14(12):717-734. https:\/\/doi.org\/10.1038\/nrclinonc.2017.101","DOI":"10.1038\/nrclinonc.2017.101"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"[31] Xu H, Liu Z, Gao D, Li P, Shen Y, Sun Y, Xu L, Song N, Wang Y, Zhan M, Gao X, Wang Z. Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine lineage by mitochondrial pyruvate carrier (MPC). Mol Metab, 2022, 59:101466. https:\/\/doi.org\/10.1016\/j.molmet.2022.101466","DOI":"10.1016\/j.molmet.2022.101466"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"[32] Krukovets I, Legerski M, Sul P, Stenina-Adognravi O. Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist. FASEB J, 2015, 29(9):3726-3736. https:\/\/doi.org\/10.1096\/fj.14-267799","DOI":"10.1096\/fj.14-267799"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"[33] van Dooijeweert C, Deckers IAG, Baas IO, van der Wall E, van Diest PJ. Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands. Breast Cancer Res Treat, 2019, 175(2):487-497. https:\/\/doi.org\/10.1007\/s10549-019-05180-5","DOI":"10.1007\/s10549-019-05180-5"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"[34] Mahmoud SMA, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AHS, Ellis IO, Green AR. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol, 2011, 29(15):1949-1955. https:\/\/doi.org\/10.1200\/JCO.2010.30.5037","DOI":"10.1200\/JCO.2010.30.5037"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"[35] Fortis SP, Sofopoulos M, Sotiriadou NN, Haritos C, Vaxevanis CK, Anastasopoulou EA, Janssen N, Arnogiannaki N, Ardavanis A, Pawelec G, Perez SA, Baxevanis CN. Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer, 2017, 5:39. https:\/\/doi.org\/10.1186\/s40425-017-0240-7","DOI":"10.1186\/s40425-017-0240-7"},{"key":"ref35","unstructured":"[36] Matkowski R, Gisterek I, Halon A, Lacko A, Szewczyk K, Staszek U, Pudelko M, Szynglarewicz B, Szelachowska J, Zolnierek A, Kornafel J. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res, 2009, 29(7):2445-2451."},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"[37] Meng S, Li L, Zhou M, Jiang W, Niu H, Yang K. Distribution and prognostic value of tumor-infiltrating T cells in breast cancer. Mol Med Rep, 2018, 18(5):4247-4258. https:\/\/doi.org\/10.3892\/mmr.2018.9460\"","DOI":"10.3892\/mmr.2018.9460"}],"container-title":["Romanian Journal of Morphology and Embryology"],"original-title":[],"link":[{"URL":"https:\/\/rjme.ro\/RJME\/resources\/files\/660325553561.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:47:47Z","timestamp":1768819667000},"score":1,"resource":{"primary":{"URL":"https:\/\/rjme.ro\/archive\/66\/3\/12\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2025,12,12]]}},"URL":"https:\/\/doi.org\/10.47162\/rjme.66.3.12","relation":{},"ISSN":["1220-0522","2066-8279"],"issn-type":[{"value":"1220-0522","type":"print"},{"value":"2066-8279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}